News  |  Calendar  |  Positions

PostDoctoral Training Program Announcement

PostDoctoral Training Program Announcement

The Department of Medicine will increase infrastructure and support for its PostDoctoral fellows. The VMI’s Dr. Iain Scott, PhD, and Dr. Sruti Shiva, PhD, will direct and oversee a new PostDoctoral Training Program (PDTP) that builds and amplifies on many of the Department’s existing career development programs.

Dr. Partha Dutta Awarded New R01

Dr. Partha Dutta Awarded New R01

Congratulations to Dr. Partha Dutta who, with co-PI Dr. Radhika Muzumdar, was recently awarded a new NIH-NIA R01 titled, “Cardioprotective Role of Humanin in Aging.”

Dr. Steve Chan and collaborators identify cancer drugs that show promise for treating PH

Dr. Steve Chan Awarded New R01

Congratulations to Dr. Steve Chan who was recently awarded a new NHLBI R01 titled, “Frataxin deficiency as a cause of endothelial senescence in multiple subtypes of pulmonary hypertension.”

Welcome, Dr. Yvette Yien!

Welcome, Dr. Yvette Yien!

The Vascular Medicine Institute and Section of Benign Hematology are pleased to announce the addition of Yvette Yien, PhD, to our research community starting August 1, 2021.

Dr. Adam Straub Awarded New R01

Dr. Adam Straub Awarded New R01

Congratulations to Dr. Adam Straub who, with former VMI colleague Dr. Eric Kelley, was recently awarded a new NHLBI R01 titled, “Role of Xanthine Oxidase in Heme-induced Vascular Dysfunction.”

Celebrating VMI Women in Science

Celebrating VMI Women in Science

On International Women’s Day, and every day, we recognize the exceptional women faculty and staff of the VMI. In a particularly challenging year, our women leaders, researchers, trainees, and admins have overcome significant obstacles to do the work we value here.

Welcome to the VMI, Dr. Haodi Wu!

We are pleased to announce that Haodi Wu, PhD, will join the VMI with a primary appointment in HVI-Cardiology as an Assistant Professor in the tenure stream on October 1, 2020. Dr. Wu earned his BS from China Agriculture University and a PhD in Physiology from Peking...

Top research advances of AHA highlight Chan Lab work on BOLA3 and PH

The Chan Lab's work on BOLA3 and pulmonary hypertension was selected as a 2019 top research advance by the AHA in heart disease and stroke! Read on the AHA website: Top heart disease and stroke research advances in 2019: The American Heart Association identifies the...

Gladwin/Tejero CO R01 Competitively Renewed

Drs. Mark Gladwin and Jesus Tejero's R01 titled, “Antidote for inhaled CO poisoning based on mutationally engineered neuroglobin,” was competitively renewed with annual direct costs of $637,860 by the National Institutes of Health/National Heart, Lung, and Blood...